Ventricular fibrillation following administration of thrombolytic treatment. The EMIP experience

European Heart Journal

Volumn 17, Issue 2, 1996, Pages 213-221

  Boissel, J P ^a   Castaigne, A ^a   Mercier, C ^a   Lion, L ^a   Leizorovicz, A ^a  

^a Service de Pharmacologie Clinique   (France)

Author keywords

Acute myocardial infarction; Controlled clinical trial; Multicentre trial; Thrombolysis; Ventricular fibrillation

Indexed keywords

ANISTREPLASE; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029887891     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a014837     Document Type: Article

References (0)